The Process Development and Validation team at VGXI is responsible for optimizing and validating the processes used to manufacture DNA plasmids under Good Manufacturing Practice (GMP) standards. They ensure that production methods are efficient, scalable, and compliant with regulatory requirements, facilitating successful outcomes for human clinical trials. This team collaborates closely with various stakeholders to implement best practices and drive continuous improvement in product quality and production efficiency.